Cargando…

Pathogenetic determinants in Kawasaki disease: the haematological point of view

Kawasaki disease is a multisystemic vasculitis that can result in coronary artery lesions. It predominantly affects young children and is characterized by prolonged fever, diffuse mucosal inflammation, indurative oedema of the hands and feet, a polymorphous skin rash and non‐suppurative lymphadenopa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Principe, Domenico, Pietraforte, Donatella, Gambardella, Lucrezia, Marchesi, Alessandra, Tarissi de Jacobis, Isabella, Villani, Alberto, Malorni, Walter, Straface, Elisabetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345614/ https://www.ncbi.nlm.nih.gov/pubmed/28063205 http://dx.doi.org/10.1111/jcmm.12992

Ejemplares similares

Redox alterations of platelets and erythrocytes represent progression marker and pathogenetic determinants in Kawasaki disease
por: Straface, Elisabetta, et al.
Publicado: (2015)

Clinical characteristics of children infected with SARS-CoV-2 in Italy
por: De Jacobis, Isabella Tarissi, et al.
Publicado: (2021)

Sex differences in blood pro-oxidant status and platelet activation in children admitted with respiratory syncytial virus bronchiolitis: a pilot study
por: De Jacobis, Isabella Tarissi, et al.
Publicado: (2020)

Typical Kawasaki disease
por: Marchesi, Alessandra, et al.
Publicado: (2015)

Oxidative stress in the pathogenesis of systemic scleroderma: An overview
por: Vona, Rosa, et al.
Publicado: (2018)

The impact of the COVID-19 pandemic on eating disorders risk and symptoms: a retrospective study
por: Straface, Elisabetta, et al.
Publicado: (2023)

Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase
por: Marchesi, Alessandra, et al.
Publicado: (2018)

Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases
por: Vona, Rosa, et al.
Publicado: (2019)

Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks
por: Marchesi, Alessandra, et al.
Publicado: (2018)

Very Early Development and Recognition of Coronary Involvement in a Febrile Infant with Typical Signs of Kawasaki Disease
por: Buonsenso, D., et al.
Publicado: (2018)

Sickle Cell Disease: Role of Oxidative Stress and Antioxidant Therapy
por: Vona, Rosa, et al.
Publicado: (2021)

Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease
por: Marchesi, Alessandra, et al.
Publicado: (2021)

Estrogen receptors, ERK(1/2) phosphorylation and reactive oxidizing species in red blood cells from patients with rheumatoid arthritis
por: Di Franco, Manuela, et al.
Publicado: (2022)

The Red Blood Cell as a Gender-Associated Biomarker in Metabolic Syndrome: A Pilot Study
por: Straface, Elisabetta, et al.
Publicado: (2011)

Potential role of platelets for atherosclerotic events in rheumatoid arthritis
por: Vona, Rosa, et al.
Publicado: (2018)

Gender-Related Differences in Sickle Cell Disease in a Pediatric Cohort: A Single-Center Retrospective Study
por: Ceglie, Giulia, et al.
Publicado: (2019)

Ontogenetic and Pathogenetic Views on Somatic Chromosomal Mosaicism
por: Iourov, Ivan Y., et al.
Publicado: (2019)

Pathophysiological and clinical point of view on Kawasaki disease and MIS-C
por: Vaňková, Lenka, et al.
Publicado: (2023)

Multisystem Inflammatory Syndrome Versus Kawasaki Disease: Potential Differences in Pathogenetic and Clinical Implications
por: Yalta, Kenan, et al.
Publicado: (2023)

Sex Differences of Human Cardiac Progenitor Cells in the Biological Response to TNF-α Treatment
por: Straface, Elisabetta, et al.
Publicado: (2017)

New Insight to the Pathogenetic Mechanism of Kawasaki Disease (KD): the Relationship between Clinical Diversity and Genetic Heterogeneity
por: Yoo, Byung Won
Publicado: (2018)

On the role of autophagy in human diseases: a gender perspective
por: Lista, Pasquale, et al.
Publicado: (2011)

Aging Injury Impairs Structural Properties and Cell Signaling in Human Red Blood Cells; Açaì Berry Is a Keystone
por: Spinelli, Sara, et al.
Publicado: (2023)

Reply to Letter to the Editor: “Multisystem Inflammatory Syndrome Versus Kawasaki Disease: Potential Differences in Pathogenetic and Clinical Implications”
por: Duman, Derya, et al.
Publicado: (2023)

Autoantibodies to Estrogen Receptor α in Systemic Sclerosis (SSc) as Pathogenetic Determinants and Markers of Progression
por: Giovannetti, Antonello, et al.
Publicado: (2013)

The Pathogenetic Picture
por: Fincke, B.
Publicado: (1891)

Açaì (Euterpe oleracea) Extract Protects Human Erythrocytes from Age-Related Oxidative Stress
por: Remigante, Alessia, et al.
Publicado: (2022)

Antioxidant Activity of Quercetin in a H(2)O(2)-Induced Oxidative Stress Model in Red Blood Cells: Functional Role of Band 3 Protein
por: Remigante, Alessia, et al.
Publicado: (2022)

Pathogenetic Aspects of Systemic Sclerosis: A View Through the Prism of B Cells
por: Melissaropoulos, Konstantinos, et al.
Publicado: (2022)

Welcome to PathoGenetics
por: Ballabio, Andrea, et al.
Publicado: (2008)

Notes, Clinical and Pathogenetic
por: Berridge, E. W.
Publicado: (1885)

On the Pathogenetic Effects of Malaria
por: Munson, W. G.
Publicado: (1864)

Clinical and Pathogenetic Notes
por: Berridge, E. W.
Publicado: (1884)

Clinical and Pathogenetic Notes
por: Berridge, E. W.
Publicado: (1891)

Haematological inflammatory prognostication in COVID-19: Points to ponder!
por: Magoon, Rohan, et al.
Publicado: (2021)

Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances
por: Dammacco, Franco, et al.
Publicado: (2020)

Remak's Diagnostic and Pathogenetic Investigations
Publicado: (1847)

The RASopathies: from pathogenetics to therapeutics
por: Hebron, Katie E., et al.
Publicado: (2022)

A Pathogenetic Materia Medica
Publicado: (1895)

Pathogenetic Action of High Potencies
por: Buchmann,
Publicado: (1883)

Cannot write session to /tmp/vufind_sessions/sess_l4cdv1k3eqqpq8ikpf7bg2vdje